The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The design and statistical aspects of VIETNARMS: a strategic post-licensing trial of multiple oral direct-acting antiviral hepatitis C treatment strategies in Vietnam
Authors
Keywords
-
Journal
Trials
Volume 21, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2020-05-18
DOI
10.1186/s13063-020-04350-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Sofosbuvir-ledipasvir with or without ribavirin for chronic hepatitis C genotypes 1 and 6: real-world experience in Vietnam
- (2018) Pham Thi Thu Thuy et al. ANTIVIRAL THERAPY
- Four weeks of ledipasvir/sofosbuvir and ribavirin with or without pegylated interferon for chronic hepatitis C in non-cirrhotic people who inject drugs. A randomized trial
- (2018) Anne L.H. Øvrehus et al. JOURNAL OF HEPATOLOGY
- Dual Sofosbuvir/Daclatasvir Therapy in Adolescent Patients With Chronic Hepatitis C Infection
- (2018) Mostafa Yakoot et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Safety and efficacy of sofosbuvir plus velpatasvir with or without ribavirin for chronic hepatitis C virus infection: A systematic review and meta-analysis
- (2018) Hussien Ahmed et al. Journal of Infection and Public Health
- Short-duration treatment for chronic hepatitis C virus with daclatasvir, asunaprevir, beclabuvir and sofosbuvir (FOURward study)
- (2017) Mark S. Sulkowski et al. LIVER INTERNATIONAL
- Response Tailored Protocol Versus the Fixed 12 Weeks Course of Dual Sofosbuvir/Daclatasvir Treatment in Egyptian Patients With Chronic Hepatitis C Genotype-4 Infection: A Randomized, Open-label, Non-inferiority Trial
- (2017) Mostafa Yakoot et al. EBioMedicine
- A Bayesian response-adaptive trial in tuberculosis: The endTB trial
- (2016) Matteo Cellamare et al. Clinical Trials
- A response adaptive randomization platform trial for efficient evaluation of Ebola virus treatments: A model for pandemic response
- (2016) Scott M Berry et al. Clinical Trials
- Short-duration treatment with elbasvir/grazoprevir and sofosbuvir for hepatitis C: A randomized trial
- (2016) Eric Lawitz et al. HEPATOLOGY
- Reinventing HCV Treatment: Past and Future Perspectives
- (2016) Wendy Carter et al. JOURNAL OF CLINICAL PHARMACOLOGY
- Potential market size and impact of hepatitis C treatment in low- and middle-income countries
- (2016) M. E. Woode et al. JOURNAL OF VIRAL HEPATITIS
- Factorial versus multi-arm multi-stage designs for clinical trials with multiple treatments
- (2016) Thomas Jaki et al. STATISTICS IN MEDICINE
- Sofosbuvir plus ribavirin for the treatment of patients with chronic genotype 1 or 6 hepatitis C virus infection in Hong Kong
- (2015) C. L. Lai et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Efficacy of Ledipasvir and Sofosbuvir, With or Without Ribavirin, for 12 Weeks in Patients With HCV Genotype 3 or 6 Infection
- (2015) Edward J. Gane et al. GASTROENTEROLOGY
- Modelling hepatitis C therapy—predicting effects of treatment
- (2015) Alan S. Perelson et al. Nature Reviews Gastroenterology & Hepatology
- Tuberculosis treatment and management—an update on treatment regimens, trials, new drugs, and adjunct therapies
- (2015) Alimuddin Zumla et al. Lancet Respiratory Medicine
- The utility of Bayesian predictive probabilities for interim monitoring of clinical trials
- (2014) Benjamin R Saville et al. Clinical Trials
- Global distribution and prevalence of hepatitis C virus genotypes
- (2014) Jane P. Messina et al. HEPATOLOGY
- Daclatasvir plus Sofosbuvir for Previously Treated or Untreated Chronic HCV Infection
- (2014) Mark S. Sulkowski et al. NEW ENGLAND JOURNAL OF MEDICINE
- Correcting for multiple-testing in multi-arm trials: is it necessary and is it done?
- (2014) James M S Wason et al. Trials
- Bayesian approach to the design and analysis of non-inferiority trials for anti-infective products
- (2013) Meg A. Gamalo et al. PHARMACEUTICAL STATISTICS
- Early stopping rules in oncology: Considerations for clinicians
- (2011) Som D. Mukherjee et al. EUROPEAN JOURNAL OF CANCER
- Designs for clinical trials with time-to-event outcomes based on stopping guidelines for lack of benefit
- (2011) Patrick Royston et al. Trials
- The neglected hepatitis C virus genotypes 4, 5 and 6: an international consensus report
- (2009) Nabil Antaki et al. LIVER INTERNATIONAL
- Multi-Arm Clinical Trials of New Agents: Some Design Considerations
- (2008) B. Freidlin et al. CLINICAL CANCER RESEARCH
- A predictive probability design for phase II cancer clinical trials
- (2008) J Jack Lee et al. Clinical Trials
- Bayesian design and conduct of phase II single-arm clinical trials with binary outcomes: A tutorial
- (2007) Sarah Zohar et al. Contemporary Clinical Trials
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now